Examen de radiation de la TSX - Antibe Therapeutics Inc. (ATE)
Issuer: | Antibe Therapeutics Inc. |
Securities: | Common shares (the "Shares") |
Symbol(s): | ATE |
Delisting Date: | May 24, 2024 (at the close) |
Reason: | Failure to meet continued listing requirements. |
Trading: | The Shares will remain suspended from trading. |
Additional Information: | TSX Bulletin 2024-0219 dated April 9, 2024. |
TSX contact: | Selma Thaver, Managing Director, TSX Listings |